PL2805952T3 - Krystaliczna forma soli (6S)-5-metylotetrahydrofolianowej oraz sposób jej przygotowywania - Google Patents

Krystaliczna forma soli (6S)-5-metylotetrahydrofolianowej oraz sposób jej przygotowywania

Info

Publication number
PL2805952T3
PL2805952T3 PL12865798T PL12865798T PL2805952T3 PL 2805952 T3 PL2805952 T3 PL 2805952T3 PL 12865798 T PL12865798 T PL 12865798T PL 12865798 T PL12865798 T PL 12865798T PL 2805952 T3 PL2805952 T3 PL 2805952T3
Authority
PL
Poland
Prior art keywords
crystal form
preparing same
methyltetrahydrofolate salt
methyltetrahydrofolate
salt
Prior art date
Application number
PL12865798T
Other languages
English (en)
Polish (pl)
Inventor
Zheqing Wang
Yongzhi Cheng
Heng Huang
Huizhen LI
Original Assignee
Lianyungang Jinkang Hexin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201210018941.9A external-priority patent/CN102775407B/zh
Priority claimed from CN201210019038.4A external-priority patent/CN102584826B/zh
Priority claimed from CN201210125133.2A external-priority patent/CN102702200B/zh
Application filed by Lianyungang Jinkang Hexin Pharmaceutical Co Ltd filed Critical Lianyungang Jinkang Hexin Pharmaceutical Co Ltd
Publication of PL2805952T3 publication Critical patent/PL2805952T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B30/00—Production of single crystals or homogeneous polycrystalline material with defined structure characterised by the action of electric or magnetic fields, wave energy or other specific physical conditions
    • C30B30/06—Production of single crystals or homogeneous polycrystalline material with defined structure characterised by the action of electric or magnetic fields, wave energy or other specific physical conditions using mechanical vibrations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • C30B7/14—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions the crystallising materials being formed by chemical reactions in the solution
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Metallurgy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Mechanical Engineering (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL12865798T 2012-01-20 2012-12-17 Krystaliczna forma soli (6S)-5-metylotetrahydrofolianowej oraz sposób jej przygotowywania PL2805952T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201210018941.9A CN102775407B (zh) 2012-01-20 2012-01-20 稳定的无定型5-甲基四氢叶酸盐及其制备方法
CN201210019038.4A CN102584826B (zh) 2012-01-20 2012-01-20 (6s)-5-甲基四氢叶酸盐晶型及其制备方法
CN201210125133.2A CN102702200B (zh) 2012-04-25 2012-04-25 (6rs)-5-甲基四氢叶酸钙盐晶型及其制备方法
EP12865798.8A EP2805952B1 (en) 2012-01-20 2012-12-17 Crystal form of (6s)-5-methyltetrahydrofolate salt and method for preparing same
PCT/CN2012/086794 WO2013107236A1 (zh) 2012-01-20 2012-12-17 （6s）-5-甲基四氢叶酸盐晶型及其制备方法

Publications (1)

Publication Number Publication Date
PL2805952T3 true PL2805952T3 (pl) 2019-05-31

Family

ID=48798580

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12865798T PL2805952T3 (pl) 2012-01-20 2012-12-17 Krystaliczna forma soli (6S)-5-metylotetrahydrofolianowej oraz sposób jej przygotowywania

Country Status (11)

Country Link
US (1) US9150982B2 (OSRAM)
EP (1) EP2805952B1 (OSRAM)
JP (1) JP6166736B2 (OSRAM)
KR (1) KR101694710B1 (OSRAM)
BR (1) BR112014017939A2 (OSRAM)
CA (1) CA2861891C (OSRAM)
ES (1) ES2715599T3 (OSRAM)
HR (1) HRP20190317T1 (OSRAM)
IN (1) IN2014DN06942A (OSRAM)
PL (1) PL2805952T3 (OSRAM)
WO (1) WO2013107236A1 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015193778A1 (en) 2014-06-16 2015-12-23 Mylan Laboratories Ltd. Crystalline form of levomefolate calcium
AU2015311370B2 (en) * 2014-09-04 2020-03-26 Lianyungang Jinkang Hexin Pharmaceutical Co., Ltd. Composition of (6S)-5-methyl tetrahydrofolic acid or salt thereof as well as preparation therefor and application thereof
CA3058287A1 (en) 2017-03-31 2018-10-04 Merck Patent Gmbh Crystalline sodium salt of 5-methyl-(6s)-tetrahydrofolic acid
RU2019134064A (ru) * 2017-03-31 2021-04-30 Мерк Патент Гмбх Кристаллическая натриевая соль 5-метил-(6s)-тетрагидрофолиевой кислоты
CN112368050B (zh) * 2018-07-06 2025-12-30 默克专利股份有限公司 5-甲基-(6s)-四氢叶酸和l-缬氨酸乙酯的结晶盐
WO2021023264A1 (zh) * 2019-08-06 2021-02-11 连云港金康和信药业有限公司 用于治疗非洲猪瘟的药物组合物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223500A (en) 1977-02-22 1993-06-29 Bioresearch S.P.A. Stable pharmaceutical composition of alkaline or alkaline earth 5-methyl tetrahydrofolate
US5471001A (en) * 1994-12-15 1995-11-28 E. I. Du Pont De Nemours And Company Crystallization of adipic acid
CH693905A5 (de) * 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
DE10137017A1 (de) * 2001-07-30 2003-02-20 Basf Ag Kristallisationsverfahren zur Einstellung kleiner Partikel
RU2007145207A (ru) * 2005-05-06 2009-06-20 Гленмарк Фармасьютикалз Лимитед (In) Стронциваемая соль эзомепразола, способ ее получения и содержащее ее фармацевтические композиции
CN100336814C (zh) * 2005-11-23 2007-09-12 天津大学 溶剂超声协同作用制备球状结晶核黄素方法
KR100878140B1 (ko) * 2007-01-29 2009-01-12 한미약품 주식회사 아토바스타틴의 스트론튬염 또는 이의 수화물, 및 이를포함하는 약학 조성물
CH698729B1 (de) 2007-05-30 2009-10-15 Cerbios Pharma Sa Stabile, kristalline (6S)-N(5)-Methyl-5, 6,7,8-tetrahydrofolsäure.
CN102584826B (zh) * 2012-01-20 2015-04-29 连云港金康医药科技有限公司 (6s)-5-甲基四氢叶酸盐晶型及其制备方法
CN102702200B (zh) * 2012-04-25 2014-11-12 连云港金康和信药业有限公司 (6rs)-5-甲基四氢叶酸钙盐晶型及其制备方法
CN102775407B (zh) * 2012-01-20 2015-08-05 连云港金康医药科技有限公司 稳定的无定型5-甲基四氢叶酸盐及其制备方法

Also Published As

Publication number Publication date
JP2015506941A (ja) 2015-03-05
EP2805952A4 (en) 2015-07-01
IN2014DN06942A (OSRAM) 2015-04-10
WO2013107236A1 (zh) 2013-07-25
BR112014017939A8 (pt) 2017-07-11
KR20140113740A (ko) 2014-09-24
US9150982B2 (en) 2015-10-06
ES2715599T3 (es) 2019-06-05
CA2861891C (en) 2018-06-19
HRP20190317T1 (hr) 2019-05-03
KR101694710B1 (ko) 2017-01-10
BR112014017939A2 (pt) 2021-05-25
EP2805952A1 (en) 2014-11-26
JP6166736B2 (ja) 2017-07-19
EP2805952B1 (en) 2019-02-06
US20150018357A1 (en) 2015-01-15
CA2861891A1 (en) 2013-07-25

Similar Documents

Publication Publication Date Title
IL273276A (en) salt crystals
IL241089B (en) A salt of omacamtib from carbyl and a process for making a salt
SG11201503113VA (en) Method for forming of siliceous film and siliceous film formed using same
ZA201305972B (en) Method for the preparation of biphephos
PL2722331T3 (pl) Kryształ soli disodowej pirolochinolinochinonu oraz sposób jego wytwarzania
ZA201503159B (en) Small crystal ferrierite and method of making the same
EP2930169A4 (en) CRYSTALLINE FORM OF CHIDAMIDE, PREPARATION METHOD AND USE THEREOF
PL2785701T3 (pl) Krystaliczna postać kabazytakselu i sposób jej otrzymywania
EP2852403A4 (en) METHOD FOR MODIFYING TISSUE
EP2927226A4 (en) MONOHYDRATE CRYSTAL FROM FIMASARTANKALIUM SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACOLOGICAL COMPOSITION THEREWITH
IL231505A0 (en) Pharmaceutical preparation and method for its production
EP2807261A4 (en) PROCESS FOR CULTIVATION OF MONARDA FISTULOSA
HRP20190317T1 (hr) Kristalni oblik (6s)-5-metiltetrahidrofolatne soli i metoda za pripremanje istog
GB201215942D0 (en) Method of treatent
EP2889303A4 (en) CONNECTION OF A CRYSTAL FORM OF ANDROSTA-3B, 5A, 6B-TRIOL AND METHOD FOR THE PRODUCTION THEREOF
EP2850057A4 (en) PROCESS FOR THE PREPARATION OF THIADIAZOLENE
PT2998305T (pt) Cristal de sal de lítio de pirroloquinolina quinona e seu método de preparação e aplicação
IL234080A (en) Tetrazolylhydroxyimino derivatives and methods for their production
IL238934A0 (en) Methods for the preparation of phenyloxymethyl-nitro-imidazole derivatives and their use
ZA201501374B (en) Amine salt and crystals thereof
EP2691387A4 (en) PROCESS FOR THE PREPARATION OF THE CRYSTALLINE FORM II OF ANHYDROUS ARIPIPRAZOLE
GB201210519D0 (en) Apparatus and method for crystal growth
GB201110438D0 (en) Carton locking means and method of use thereof
GB201210201D0 (en) Carton locking means and method of use thereof
HUP1000616A2 (en) Process for preparation of rosuvastatin salt